Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

Expression of concern: non-steroidal anti-inflammatory drugs and the risk of oral cancer.

Horton R.

Lancet. 2006 Jan 21;367(9506):196. No abstract available.

PMID:
16427477
2.

The efficacy of oral non-steroidal anti-inflammatory drugs for rotator cuff tendinopathy: a systematic review and meta-analysis.

Boudreault J, Desmeules F, Roy JS, Dionne C, Frémont P, Macdermid JC.

J Rehabil Med. 2014 Apr;46(4):294-306. doi: 10.2340/16501977-1800. Review.

3.

Defining patients at risk of non-steroidal anti-inflammatory drug gastropathy.

Russell RI.

Ital J Gastroenterol Hepatol. 1999;31 Suppl 1:S14-8. Review.

PMID:
10379464
4.

Systematic review: the hepatotoxicity of non-steroidal anti-inflammatory drugs.

Rubenstein JH, Laine L.

Aliment Pharmacol Ther. 2004 Aug 15;20(4):373-80. Review.

5.

Helicobacter pylori eradication may reduce the risk of gastroduodenal lesions in chronic NSAID users.

Russell RI.

Ital J Gastroenterol Hepatol. 1997 Oct;29(5):465-9. Review.

PMID:
9494858
6.

Review article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer.

Jalving M, Koornstra JJ, De Jong S, De Vries EG, Kleibeuker JH.

Aliment Pharmacol Ther. 2005 Feb 15;21(4):321-39. Review.

7.

Oral non-steroidal anti-inflammatory drug therapy for cystic fibrosis.

Dezateux C, Crighton A.

Cochrane Database Syst Rev. 2000;(2):CD001505. Review. Update in: Cochrane Database Syst Rev. 2007;(4):CD001505.

PMID:
10796797
9.

Role of chemoprophylaxis with either NSAIDs or statins in patients with Barrett's esophagus.

Tsibouris P, Vlachou E, Isaacs PE.

World J Gastrointest Pharmacol Ther. 2014 Feb 6;5(1):27-39. doi: 10.4292/wjgpt.v5.i1.27. Review.

10.

Non-steroidal anti-inflammatory drugs and gastrointestinal bleeding.

Lanas A.

Ital J Gastroenterol Hepatol. 1999;31 Suppl 1:S37-42. Review.

PMID:
10379468
11.

Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis.

Lands LC, Stanojevic S.

Cochrane Database Syst Rev. 2016 Apr 7;4:CD001505. doi: 10.1002/14651858.CD001505.pub4. Review.

PMID:
27055154
12.

Utilization patterns of non-steroidal anti-inflammatory drugs in an open Dutch population.

Leufkens HG, Ameling CB, Hekster YA, Bakker A.

Pharm Weekbl Sci. 1990 Jun 22;12(3):97-103. Review.

PMID:
2196532
13.

A clinical approach to management of patients with non-steroidal anti-inflammatory gastropathy.

Yeomans ND.

Ital J Gastroenterol Hepatol. 1999;31 Suppl 1:S89-92. Review.

PMID:
10379475
14.

Lead optimization on conventional non-steroidal anti-inflammatory drugs: an approach to reduce gastrointestinal toxicity.

Narsinghani T, Sharma R.

Chem Biol Drug Des. 2014 Jul;84(1):1-23. doi: 10.1111/cbdd.12292. Epub 2014 Mar 13. Review.

PMID:
24460671
15.

Mechanism of non-steroidal anti-inflammatory drug-gastropathy.

Fiorucci S, Antonelli E, Morelli A.

Dig Liver Dis. 2001 Dec;33 Suppl 2:S35-43. Review.

PMID:
11827361
16.
17.

[Acute cervical necrotizing fasciitis of pharyngeal origin: possible role of steroidal and non-steroidal anti-inflammatory agents. Apropos of 5 cases].

Chaplain A, Gouello JP, Dubin J.

Rev Laryngol Otol Rhinol (Bord). 1996;117(5):377-80. Review. French.

PMID:
9183910
18.
19.

Prophylaxis and treatment of non-steroidal anti-inflammatory drug-induced upper gastrointestinal side-effects.

Lazzaroni M, Bianchi Porro G.

Dig Liver Dis. 2001 Dec;33 Suppl 2:S44-58. Review.

PMID:
11827362
20.

Coxibs, non-steroidal anti-inflammatory drugs and cardiovascular risk.

Hermann M, Ruschitzka F.

Intern Med J. 2006 May;36(5):308-19. Review. Erratum in: Intern Med J. 2006 Dec;36(12):799.

PMID:
16650196

Supplemental Content

Support Center